BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21685422)

  • 1. Anthelmintic resistance: potential benefits of 'over-diagnosis'.
    Sargison ND; Scott PR
    Vet Rec; 2011 Jun; 168(24):646-7. PubMed ID: 21685422
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep.
    Turner K; Armour J; Richards RJ
    Vet Rec; 1984 Jan; 114(2):41-2. PubMed ID: 6719804
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance of Fasciola hepatica to triclabendazole.
    Overend DJ; Bowen FL
    Aust Vet J; 1995 Jul; 72(7):275-6. PubMed ID: 8534235
    [No Abstract]   [Full Text] [Related]  

  • 4. Triclabendazole-resistant liver fluke in Scottish sheep.
    Mitchell GB; Maris L; Bonniwell MA
    Vet Rec; 1998 Oct; 143(14):399. PubMed ID: 9802201
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of reversion in triclabendazole-resistant Fasciola hepatica.
    Borgsteede FH; Moll L; Vellema P; Gaasenbeek CP
    Vet Rec; 2005 Mar; 156(11):350-1. PubMed ID: 15789649
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of closantel against adult triclabendazole-resistant Fasciola hepatica.
    Coles GC; Rhodes AC; Stafford KA
    Vet Rec; 2000 Apr; 146(17):504. PubMed ID: 10888001
    [No Abstract]   [Full Text] [Related]  

  • 7. Triclabendazole-resistant Fasciola hepatica in southwest Wales.
    Thomas I; Coles GC; Duffus K
    Vet Rec; 2000 Feb; 146(7):200. PubMed ID: 10718597
    [No Abstract]   [Full Text] [Related]  

  • 8. Raising the bar on reporting 'triclabendazole resistance'.
    Fairweather I
    Vet Rec; 2011 May; 168(19):514-5. PubMed ID: 21571852
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain.
    Alvarez-Sánchez MA; Mainar-Jaime RC; Pérez-García J; Rojo-Vázquez FA
    Vet Rec; 2006 Sep; 159(13):424-5. PubMed ID: 16998003
    [No Abstract]   [Full Text] [Related]  

  • 10. Increase of carboxylesterase activity in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Miranda-Miranda E; Cossío-Bayúgar R; Ceballos L; Fernandez V; Solana H
    Mol Biochem Parasitol; 2012 Oct; 185(2):151-3. PubMed ID: 22814337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of triclabendazole against Fasciola hepatica in sheep and goats.
    Wolff K; Eckert J; Schneiter G; Lutz H
    Vet Parasitol; 1983 Sep; 13(2):145-50. PubMed ID: 6685399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of resistance to triclabendazole.
    Jones EM; Daniel R; Coles GC
    Vet Rec; 2014 May; 174(22):560. PubMed ID: 24920715
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
    Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
    Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
    Fawcett AR
    Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fasciolinip-1: experimental fasciolicidal activity in sheep].
    Ibarra-Velarde F; Vera-Montenegro Y; Olazarán-Jenkins S; Hernández-Campos A; Castillo-Bocanegra R
    Rev Latinoam Microbiol; 1995; 37(2):171-8. PubMed ID: 8552877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extension of the prepatent period of Fasciola hepatica in infected animals following treatment with triclabendazole.
    Büscher G; Bowen FL; Strong MB; Allison JR; Richards RJ
    Vet Rec; 1987 May; 120(19):460-1. PubMed ID: 3603988
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of an anthelmintic combination in sheep infected with Fasciola hepatica resistant to albendazole and clorsulon.
    Martínez-Valladares M; Cordero-Pérez C; Rojo-Vázquez FA
    Exp Parasitol; 2014 Jan; 136():59-62. PubMed ID: 24211419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.
    Novobilský A; Amaya Solis N; Skarin M; Höglund J
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):141-147. PubMed ID: 27380550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anthelmintic activity of some benzimidazole derivatives against Fasciola hepatica.
    Chevis RA; Kelly JD
    N Z Vet J; 1978 Sep; 26(9):218-20. PubMed ID: 281659
    [No Abstract]   [Full Text] [Related]  

  • 20. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.